Crossmark

Clinical impact of targeted next-generation sequencing in paediatric pneumonia management: a real-world study evaluating diagnostic concordance and antimicrobial stewardship across multiple specimen types

Crossref DOI link: https://doi.org/10.1186/s13052-025-02189-z

Published Online: 2026-01-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lin, Feijin

Sang, Gao

Wang, Zheqi

Kong, Mingang

Chen, Qian
Funding

Funding for this research was provided by:

The Construction Fund of Key Medical Disciplines of Hangzhou (2025HZZD19)
License Information

Text and Data Mining valid from 2026-01-12

Version of Record valid from 2026-02-09
More Information

Article History

Received: 31 August 2025

Accepted: 21 December 2025

First Online: 12 January 2026

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hangzhou Children’s Hospital (Approval Number: IRB-2025-049(IIT)). The study protocol was approved by the institutional review board with a waiver of informed consent due to the retrospective nature and minimal risk to participants.

: Not applicable.

: None of the authors have any personal, financial, commercial, or academic conflicts of interest.

Document is current

Any future updates will be listed below